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ABSTRACT
Objectives: The management of anaesthesia for patients with large myomas is particularly 
important due to disruption of hemodynamic as a result of massive haemorrhage, the prolonged 
duration of surgery and requirement for additional interventions. This study evaluated the effect 
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of anaesthetic technique on blood loss in patients undergoing myomectomy due to large fibroid 
uterus. 
Material and methods: A total of 156 patients that underwent myomectomy were randomized 
into two equal groups according to the type of anaesthesia: Epidural anaesthesia group and 
General anaesthesia group. The volume of blood loss and blood products transfusion was 
reviewed for each patient. 
Results: The intraoperative blood loss and need for blood transfusion were significantly higher 
in general anaesthesia group (p < 0.001). The mean hematocrit change was 2.5 ± 1.5 vs 3.7 ± 2.9 
% (p = 0.001) for both groups. 
Conclusions: In the myomectomy planning of women with a large fibroid uterus, the team of 
gynecologists and anaesthesiologists should take care to choose the most optimal technique for 
anaesthesia.
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INTRODUCTION
Uterine leiomyomas are the most common benign tumor of the reproductive system in 
women of childbearing age [1]. A hysterectomy is the optimum treatment for symptomatic 
fibroids. However, for patients who seek future pregnancy or preservation of the uterus, 
myomectomy is a popular option [2]. Abdominal fibroid enucleation is often preferred over 
laparoscopic myomectomy in the cases of large and multiple leiomyomas [3]. Intraoperative 
bleeding requiring blood transfusion is the most common complication of an abdominal 
myomectomy [4] and, when uncontrolled, may require a hysterectomy [5]. 
The amount of blood transfusion in open myomectomy depends on the size of the uterus 
and the number and site of fibroids [3]. The overall rate of a blood transfusion during abdominal 
myomectomy is 13.5 to 58.2% [6], with an unpredictable rate of hysterectomy about 2% after 
uncontrolled bleeding [2, 6]. Therefore, during myomectomy, effective measures to reduce blood
loss are desirable [2].
A number of medical and surgical techniques have been attempted to significantly reduce 
bleeding during myomectomy. This includes peri-operative vaginal misoprostol and 
dinoprostone, intraoperative vasopressin, intrauterine bupivacaine and epinephrine, intravenous 
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tranexamic acid and ascorbic acid, gelatin-thrombin matrix, loop ligation of the pseudo-capsule 
of the leiomyoma, and by using a foley catheter as a cervical tourniquet [7]. However, each 
technique has its limitations; therefore, blood loss control remains the main goal for both 
anaesthesiologists and gynaecologists [8]. 
To our knowledge, no published study had systematically assessed the effectiveness of 
epidural anaesthesia and myomectomy. Hypotensive technique during anaesthesia allowed for a 
significant reduction in blood loss without compromising the perfusion of vital organs [9], 
thereby reducing transfusion requirements and reducing the risk of allogeneic transfusion [10].
This study was conducted to determine the amount of blood loss during surgery and to 
find the optimum perioperative anaesthetic method in patients undergoing myomectomy for 
treatment of large fibroids. The primary outcome measure was estimated blood loss during 
myomectomy. The secondary outcome measures were the amount of blood transfusions during 
surgery, intraoperative recourse to hysterectomy and post-operative change in haematocrit.
MATERIAL AND METHODS
Study design 
This prospective randomized clinical study was conducted between June 2014 and May 
2019 at Sabah Maternity Hospital — a tertiary health facility in Kuwait. The Sabah Maternity 
Hospital has 320 beds, with an annual rate of about 4000 gynaecologic admissions. 
Ethical consideration
The study protocol was approved by the ethical review committee of the Sabah Maternity
Hospital, Kuwait before commencement of the study and it was post-registered at 
ClinicalTrials.gov (NCT04629573). Written and informed consent was obtained from all patients
after thorough explanations about study purpose, design, and procedures to each patient.
Eligibility criteria
Patients over 18 years of age, American Society of Anesthesiologist (ASA) I and II, 
undergoing myomectomy to treat large uterine leiomyomas (with a diameter of at least 10 cm as 
diagnosed by transvaginal ultrasonography) were included in this study. Exclusion criteria: 
Patients with a history of previous uterine surgery (myomectomy, caesarean delivery), 
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coagulopathy or other bleeding diathesis and severe anaemia (Hb under 7.0 g/dL) were excluded 
from the study. 
Study Groups 
A total of 156 patients were randomized into two equal groups according to the type of 
anaesthesia, 78 patients in each group: Epidural anesthesia group (Group I) and General 
anesthesia group (Group II).
Randomization and blinding
The management protocol for each group was prepared by the researchers before the 
study began and sealed one protocol per envelope with a computer-generated number assigned 
prior to study initiation. Randomization was performed by selecting sequentially numbered 
envelopes and opening them before induction of anaesthesia by the anaesthetist and managing 
the participant according to the attached protocol. The study will not be double-blind, as 
healthcare professionals and patients cannot afford to ignore a strategy to which the woman is 
allocated.
Interventions 
Anaesthesia procedures: Upon arrival to the operative theatre, an 18- gauge IV catheter 
was inserted and 500 mL of NaCl (0.9%) was administered, 1 mg of intravenous midazolam was 
given as premedication. Patients were monitored by ECG, pulse oximetry and non-invasive 
blood pressure regularly every five minutes.
Lumbar epidural. Epidural procedures were performed by attending anaesthesiologists 
who performed at least 50 epidural procedures during their studies The Patient was placed in a 
sitting position, the skin in the lumbar region was cleaned and sterilization procedures were 
followed throughout the procedure. The skin and subcutaneous tissue were infiltrated with 2mL 
of 1% lidocaine at the site of epidural placement (L2-3 or L3-4 interspace). The lumbar epidural 
space was localised, using a midline approach with an 18-gauge Tuohy epidural needle by loss of
resistance technique with 2 mL of saline, 20-gauge epidural catheter was inserted in each patient.
An initial bolus dose of 20 mL bupivacaine 0.5% plus 100 mcg Fentanyl was given through the 
epidural catheter, followed by continuous infusion of bupivacaine 0.5% plus 1mcg/ml Fentanyl 
(3–5 mL/h). 
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General anaesthesia. Anaesthesia was started with IV 1 µg/kg fentanyl, 2 mg/kg propofol and 
0.15 mg/kg cisatracurium to facilitate endotracheal intubation. After tracheal intubation, 
anaesthesia was maintained with sevoflurane in O2 and air (FiO2 of 0.5), and intravenous 
infusion of 1µg/kg/min cisatracurium and 0.5 µg/kg/h fentanyl. Volume-Controlled ventilation 
was performed in all patients. Cisatracurium and fentanyl infusion was discontinued at the end of
surgery, neuromuscular blockade was reversed, and the patient was extubated and send to post-
anaesthesia care unit. 
Myomectomy. Abdominal myomectomy was performed using standard conventional techniques.
One of the surgeons oversaw all operations. The myomectomy was performed by excision of 
uterine fibroids and closing the uterine defect in several layers. The use of electrical devices, type
of suture, and adhesion barriers were at the surgeon's discretion. 
Data collection
All participants had standard preoperative evaluations including pelvic ultrasound for the 
size, number and site of leiomyomas. T2-weighted MRI imaging of leiomyoma was a more 
precise method for measuring leiomyoma volume [11]. Age, parity, body mass index, surgical 
history, number of previous caesarean sections, indication of myomectomy, intraoperative 
anaesthetic management, ASA classification, pre and postoperative Hgb and Hct values, number 
of fibroids, fibroid dimension and location, suture type, number of layers of closure, concomitant
procedures, duration of operation, intraoperative complications.
Outcome measures. The primary outcome was estimated intraoperative blood loss. 
Intraoperative blood loss was estimated by measuring the volume of blood in suction bottle; 
other losses were calculated using the gravimetric methods by scanning the pre-weighted 
abdominal towels and repeating the measurement with a weight difference of 1 gram equal to 1 
ml of blood. Secondary outcomes include need for blood transfusions, need for hysterectomy and
total blood loss calculations.
Blood loss calculations. The patient’s estimated blood volume (EBV) using the Nadler equation
[12]: 
EBV (L) = 0.3561 × height (m) 3 + 0.03308 × weight (kg) + 0.1833 (for female)
The amount of intra and post-operative blood loss (TBL) was determined by a comprehensive 
method that is widely used to measure blood loss perioperatively [13]:
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TBL (L) = EBV (L) × (preoperative Hct - postoperative Hct) / average Hct
Average Hct is the average of haematocrit before and after surgery. In our study, Postoperative 
Hct was defined as Hct on the day three after myomectomy. To reduce the risk of haemodilution 
at the expense of blood loss, our patients didn’t receive more than 2000 mL of IV fluid intra or 
post-operative. 
Blood transfusions. Blood transfusion was initiated when the maximum calculated allowable 
blood loss (transfusion trigger) was exceeded. Ttransfusion of blood and blood products was also
initiated with signs of cardiovascular instability or inadequate perfusion or oxygenation. In 
addition, fresh-frozen plasma (unit), tranexamic acid, human fibrinogen concentrates, crystalloid 
(mL), and colloid (mL) transfusions were also reviewed.
Sample size calculation. The sample size was calculated by Epi Info software Version 7.2 for 
Windows. Based on previous study [14], if the standard deviation of blood loss is 1721 mL, this 
study should consist of 73 patients in each group (sample size), to achieve a power of 95% and 
5% of significance level (two sided) and to detect a true difference in means between the test and
the reference group of 964 mL. Ten patients were added to the sample to compensate for 
dropouts. 
Statistical analysis
SPSS for Windows 23.0 statistical program (IBM Corp., Armonk, NY, US) was used for 
data analysis. Continuous variables were represented as median (minimum-maximum) and 
categorical variables were expressed as frequencies and percentages. Pairwise comparisons were 
performed using the Mann-Whitney U test. Chi-square test was used to compare the categorical 
variables. P < 0.05 value was considered significant.
RESULTS
A total of 202 women were selected for the eligibility criteria within the study. Then, 156 
women of the total selected were participated in our study, 78 in each group as show in consort 
flow diagram. 
The mean age of the participants was 39.15 ± 4.14 (range, 22–45) years; 66 (42.3%) were
nulliparous, and 94 (60.2%) had no children. Common symptoms were excessive and or 
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prolonged menstruation (n = 61; 39.1%), abdominal pain (n  =25; 16%), inability to conceive (n 
= 33; 21.15%), mechanical complaints (n = 31; 19.87%) and 6 (3.8%) had other symptoms (Tab. 
1). 
Both treatment groups were similar with no statistically significant difference in demographic 
data and preoperative Hb level (Tab. 1). However, the treatment groups differed in characteristics
of the fibroids (size, type, volume and numbers), due to lack of stratification of patients 
according to the size of the myomas. The mean diameter of the largest fibroid was significantly 
higher in women allocated to group I (Epidural anesthesia) than women allocated to group II 
(general anesthesia) 14.5 ± 2.3 vs. 11.7 ± 1.6 cm; P = 0.035; 95% CI 0.1–2.0). Other 
characteristics of the fibroids at baseline such as type (subserous, interstitial and submucous), 
volume of the uterus and the leiomyoma volume planned for excision did not reveal a significant 
difference (Tab. 2).
Table 3 showed that group II participants recorded higher values in mean intraoperative 
blood loss [984 ± 345 vs. 745 ± 289 mL, (p = <0.001)] and blood products transfusion including 
PRBCs, FFP and Platelets [48 (61. 53%) vs. 29 (37.17%), (p = 0.008)] than group I. Blood 
transfusions were performed on one patient (1.2%) in group I, and three patients (3.8 %) in group
II postoperative. In group II (under general anaesthesia), four patients and in group I, two 
patients (under epidural anaesthesia but subsequently converted to general anaesthesia) were 
subjected to hysterectomy. 
The mean preoperative haematocrit was 31.8 ± 3.6 vs. 31.9 ± 4.2% (p = 0.87), the mean 
post-operative haematocrit was 27.4 ± 2.1 vs. 24.01 ± 1.3% (p = < 0.001), and the mean 
haematocrit change was 4.4 ± 1.5 vs. 7.8 ± 1.9% (p = 0.03) for groups I and II, respectively (Fig. 
1). Of the 40 patients who received intraoperative blood transfusion in both groups (group I 15 
and group II 25), the change in haematocrit between group I and group II were in the range of 2–
10.5% and this was statistically significant.  
DISCUSSION
Myomectomy can increase the morbidities and the rate of mortality [15], especially when
hysterectomy is performed [16]. Intraoperative complications, such as DIC, fluid overload, 
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ARDS, and hemodynamic disturbances that may necessitate blood transfusion may threaten the 
patient health [17]. Therefore, anaesthetic management in these patients must be well-planned.  
General anaesthesia has been reported to be less effective in reducing blood loss in myomectomy
compared with epidural anaesthesia. Our study showed that the mean of intraoperative blood 
loss, blood transfusion rate and number of transfused blood units were higher (statistically 
significant) among group II (patients who underwent general anaesthesia) compared to group I 
(those who underwent epidural anaesthesia). However, change in haematocrit level after 
myomectomy and blood transfusion rate were more pronounced in the group under general 
anaesthesia. In this study, the mean blood loss in group under epidural anaesthesia was greater 
than in previous reports[18–20]. Systematic reviews have shown that these studies had lower 
amount of blood loss due to decreased uterine size to < than 24 weeks [20], 8.7 ± 4.6 weeks[19] 
and 15.7 ± 2.6 weeks [18] compared with 18.50 ± 4.72 weeks in this study. Our study showed 
increase in blood loss during myomectomy because blood loss is proportionate to the size of the 
uterus. The number of fibroids was associated with increase in blood loss, which explains the 
lower bleeding amount in the Turkish study with the average number of leiomyomas of 5.5 ± 1
[18] compared with 8.25 ± 3.56 in this study. The calculation of blood loss during abdominal 
myomectomy remains paramount. The studies in Turkey [18] and Iran [19] , measured blood loss
from the blood in the suction bottle but our study evaluated other losses plus the suction bottle 
using weight measurement method, this justify the increase in blood loss in this study.
In our study, the intra-operative blood transfusion rate was 19.8%, similar to reports with 
previous studies 15.3% [18] and 24% [20]; some studies reported no blood transfusion 
requirement [19], our study has myomas with larger size, uterine sizes more than 24 weeks in 
some patients and presence of multiple fibroids in many patients. 
Maximum blood loss was 2580 mL in patients who underwent general anaesthesia and 
1650 ml in patients who underwent epidural anaesthesia. Three or fewer units of RBC 
transfusion were required only in 11 (14.1%) patients who underwent epidural anaesthesia, while
one patient only required more than three units of transfusion. While 13 (16.66%) patients 
undergoing general anaesthesia required three or fewer RBC transfusion units and 6 (7.7%) 
required more than three units. Accordingly, transfusion of RBCs and human fibrinogen 
concentrate were significantly higher (p < 0.001) in group II (patients under general anaesthesia) 
compared to group I (patients under epidural anaesthesia).
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On the time, there is no consensus when to start blood transfusion during myomectomy 
procedure, in our study transfusion was started when the calculated maximum tolerated blood 
loss or signs of cardiovascular instability from massive bleeding was reached. However, another 
study used a loss of 2000 ml as an indication to start blood transfusion [19].
The previous studies suggest that epidural anaesthesia may be a better and safer option 
than general anaesthesia for surgeries with massive bleeding that need to initiate blood 
transfusion, as inhaled anaesthetics can cause uterine relaxation and thereby increase blood loss 
and increase the need for blood transfusion [21]. An earlier study reported that regional 
anaesthesia reduced intraoperative blood loss due to sympathetic blockade [22]. Lilker et al. [23] 
concluded that most patients undergoing surgeries with massive bleeding could tolerate 
prolonged surgery and excessive blood loss under epidural anaesthesia.
Only two patients in this study who underwent epidural anaesthesia were switched to 
general anaesthesia because of the hemodynamic instability caused by severe bleeding.  In our 
study hysterectomy was the main cause of the change to general anaesthesia where hysterectomy
was performed in six patients (3.8%), four under general anaesthesia and two starting to have 
epidural anesthesia but switching to general anaesthesia before hysterectomy.
Several studies [24, 25] have shown  that angiogenesis is a prerequisite for tumor growth.
VEGF-C is an important factor in the development of angiogenesis, increases mitogenic and 
vascular permeability activity, and is specific to endothelial cells. Zhang et al. noted that there is 
a correlation between anaesthesia and serum VEGF-C level. They also suggest in their study that
the recurrence rate of myomas and progression of postoperative leiomyomas can be reduced in 
patients undergoing spinal and epidural anesthesia [26]. 
The strengths of this study include the prospective nature, randomized design, the 
detailed registry of surgical parameters, the accuracy of estimated blood loss and the use of a 
regression model to account for potential confounding factors related to operative blood loss. A 
discussion of how epidural anaesthesia affects excessive blood loss may be more clinically useful
and further research is needed. 
CONCLUSIONS
In women with large fibroid uterus planning for surgical removal, gynecology-
anaesthesia team should be careful to choose the best anaesthetic technique, taking into account 
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the location and the size of myoma, expected volume of blood loss, and surgical complications, 
for patient safety.
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Age (years) 38.2 ± 4.9 39.4 ± 3.8 0.165
Parity 1 (0–3) 2 (0–5) 0.128
BMI (kg/m2) 25.2 (19.6–36.7) 25.8 (20.2–
38.7)
0.439
Hemoglobin (mg/dL) 9.8  ± 1.6 9.5 ± 1.3 0.722
Indication for surgery


































Previous abdominal surgery 18 (23) 12 (15.3) 0.285
Qualitative data were described using numbers and percent while normally quantitative data 
were expressed in Mean ± SD and abnormally distributed data were expressed in median (Min-
Max.); * — Significant p value < 0.05; BMI — Body mass index
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 Aggregate weight (g)
 Largest diameter (cm)


















































Uterine cavity opened 18 (23%) 12 (115.3%) 0.054
Qualitative data were described using numbers and percent while normally quantitative data 
were expressed in Mean ± SD and abnormally distributed data were expressed in median (Min-
Max.). * — Significant p value < 0.05
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Operative time (min) 101 ±0.693 106 ±1.525 0.167
Estimate blood loss (mL) 745  ± 289 984 ± 345 < 0.001*
Blood products transfusion
 RBCs









Need for hysterectomy 2 (2.56%) 4 (5.12%) 0.523
Postoperative Complications
 ileus
 DVT or PE











Hospital stay (Less than 2 days) 46 40 0.004*
Qualitative data were described using numbers and percent while normally quantitative data 
were expressed in Mean ± SD and abnormally distributed data were expressed in median (Min-
Max.); * — Significant p value < 0.05. RBCs — Red Blood Cell; DVT — Deep Venous 
Thrombosis; PE — Pulmonary Embolism
Figure 1.  Preoperative, postoperative hematocrit (HCT) level and the mean HCT change in the 
two groups
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Epidural anesthesia group General anesthesia group
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